Examples of using Tilray in English and their translations into German
{-}
-
Colloquial
-
Official
-
Ecclesiastic
-
Medicine
-
Financial
-
Ecclesiastic
-
Political
-
Computer
-
Programming
-
Official/political
-
Political
Is it possible to earn profits with Tilray Inc. Stocks?
Tilray products are currently available at pharmacies in several EU countries.
Secured purchase agreements with Tilray® for a 10kW REV TM machine and two 60kW REV TM machines.
Tilray made its IPO on the NASDAQ in August of 2018, at a unit price of USD 23.
It is very likely that the opportunity to make a big profit from investing in Tilray has already passed.
Tilray® purchase d a second large-scale 60kW REV TM machine to be installed in Portugal.
Under the terms of the expanded License, Tilray will pay royalties based on the amount of cannabis processed using the REVTM equipment.
Tilray is a global pioneer in the research, cultivation, processing and distribution of medical cannabis and cannabinoids.
Based on the approval of the Ministry of Health,Immunology imported a series of drug manufacturers Tilray from Canada, a wholesaler PHOENIX Pharmacy d. o. o.
Tilray is one of a select number of licensed companies which are GMP-certified for cultivation, import, release and distribution.
After the Recruitment and Use of Cannabis for recreationaluse took effect in Canada in June, Tilray became the first company in the industry to go public.
I n June 2016, Tilray became the first company to legally export medical cannabis products from North America to the Europe an Union the"EU.
In a study with 19 children with Dravetsyndrome a cannabis extract produced by the company Tilray containing 100 mg/ml CBD and 2 mg/ml THC reduced the number of seizures and improved quality of life.
The License grants Tilray an exclusive right to use and sub-license the Company's proprietary REVTM dehydration technology in Canada for specific applications.
Launched REV TM technology into the rapidly growing cannabis industry andsigned a royalty-bearing C ommercial L icense A greement("CLA") with Tilray® providing rights to use REV TM technology for processing cannabis in Canada and Portugal.
Under the terms of the License, EnWave and Tilray share royalties from Y our Wasabi Farm 's use of EnWave's REVTM technology on an undisclosed basis.
Forward-looking statements in this press release may be identified by the use of words such as," may"," would"," could"," will"," likely"," expect"," anticipate"," believe," intend"," plan"," forecast"," project"," estimate"," outlook" and other similar expressions and include statementsrelating to the AB InBev and Tilray partnership, the potential investment of each party and the possibility of commercialization at some point in the future.
The Company's strategy, in partnership with Tilray, is to secure additional royalty bearing sub-licenses with additional licensed producers in the cannabis sector.
About Tilray® TilrayÂ(NASDAQ: TLRY) is a global pioneer in the research, cultivation, production and distribution of cannabis and cannabinoids currently serving tens of thousands of patients in twelve countries spanning five continents.
EnWave signed a royalty-bearing commercial license agreement with Tilray®, a major licensed producer in Canada, and received purchase orders for 10kW REV TM and 60kW REV TM machinery.
EnWave and Tilray entered into an exclusive partnership in October 201 7 in which EnWave named Tilray as its licensed partner under the terms of an exclusive, sub-licensable, royalty bearing commercial license the"License.
As elderly medical cannabis use is a new phenomenon it hasbecome the focus of a new study launched by Tilray Canada which aims to assess the impact of medical cannabis on chronic pain, sleep patterns, and the quality of life in patients over 50 years of age distributed throughout Canada.
The Company, in partnership with Tilray®, will pursue additional commercial opportunities for REVTM within the Canadian cannabis sector through a sub-licensing structure outlined in the current agreement.
Canadian cannabis producer and distributor Tilray said it had partnered with local company Alef Biotechnology, which is licensed by the Chilean government.
In addition to the Tilray® license, EnWave also signed royalty-bearing commercial license agreements with Howe Foods, the second largest banana producer in Australia, and AvoLov L LC, a U. S.
With strong track records of responsibleproduct development and marketing in their respective industries, AB InBev and Tilray believe that the legal market for THC and CBD beverages will only thrive if the industry embraces appropriate regulation of adult-use cannabis, including responsible production, marketing, sale and consumption.
In order to exercise the Option, Tilray must submit a purchase order for large-scale REV TM machinery in the first half of calendar year 2018, and pay the deposit required thereunder, to be installed in Portugal for commercial processing of cannabis products.
TORONTO--(BUSINESS WIRE)--Today, AB InBev, the world's leading brewer, and Tilray, a global pioneer in cannabis production and distribution, announced a partnership to research non-alcohol beverages containing tetrahydrocannabinol(THC) and cannabidiol CBD.
Expanded its royalty-bearing license agreement with Tilray®, a major Canadian medical cannabis Licensed Producer, to include exclusive rights to REV TM technology for processing cannabis in the country of Portugal for processing cannabis.